Tumors isolated from mice transplanted with NIH3T3/EGFRvIII or NIH3T3/EGFRwt cells were overexpressing human EGFRvIII and EGFRwt, respectively. RNA was purified from tissue homogenates and RT-PCR was performed using primer sets (A): E1 forward and E11 reverse, (B): E13 forward and E21 reverse. Each primer was shown in (C): Primers. (PDF 250 kb
CD3 levels in 4T1 tumors grown in wild-type BALB/c mice. Samples were from the experiment shown in F...
Figure S4. (A) WNT inhibitor drug Cardamonin (CAS 19309–14-9) decreased cell proliferation in 5-8F, ...
Figure S2. Combined rhein and EGFR inhibitors synergistically suppress pancreatic cancer cell prolif...
I-Ertredin suppressed NIH3T3/EGFRvIII tumorigenicity. NIH3T3/EGFRvIII cells were subcutaneously tran...
Figure S3. Combined treatment with rhein and erlotinib inhibit tumor growth in the BxPC-3 xenograft ...
Figure S1. Efficacy of different EGFR blockers on ESCC cell lines and PDX models. (A) Six ESCC cell ...
Figure S3. JQ1 resulted in a greater reduction of tumor growth than sorafenib in vivo. (a) BEL-7402 ...
Figure S3. Estrogen promotes Brca1-proficient and deficient mammary tumor initiation (A)Â Western bl...
Effects of EGFR inhibition or activation on immortalized-human esophageal epithelial cells. EPC2-hTE...
Figure S3. CRISPR/Cas9 mediated HDACs inhibition and evaluation of tumor cell growth inhibition in e...
Figure S2. Relative mRNA levels of EGFR, ErbB2, and ErbB3 in pancreatic cancer cells. Parental HPAF-...
Assessment of receptor negative cells for E2-mediated PR upregulation. Relative steady state levels ...
Figure S1. AZD9291 pretreatment inhibited GBM cell migration. The cells were pretreated with AZD9291...
Figure S3. Characterization of the sorted EGFP+ and EGFP− cells freshly isolated from the MDA-MB-231...
Figure S1. Phosphohistone H3 (pHH3) expression and rhabdomyoblast count in VCR and ENT + VCR-treated...
CD3 levels in 4T1 tumors grown in wild-type BALB/c mice. Samples were from the experiment shown in F...
Figure S4. (A) WNT inhibitor drug Cardamonin (CAS 19309–14-9) decreased cell proliferation in 5-8F, ...
Figure S2. Combined rhein and EGFR inhibitors synergistically suppress pancreatic cancer cell prolif...
I-Ertredin suppressed NIH3T3/EGFRvIII tumorigenicity. NIH3T3/EGFRvIII cells were subcutaneously tran...
Figure S3. Combined treatment with rhein and erlotinib inhibit tumor growth in the BxPC-3 xenograft ...
Figure S1. Efficacy of different EGFR blockers on ESCC cell lines and PDX models. (A) Six ESCC cell ...
Figure S3. JQ1 resulted in a greater reduction of tumor growth than sorafenib in vivo. (a) BEL-7402 ...
Figure S3. Estrogen promotes Brca1-proficient and deficient mammary tumor initiation (A)Â Western bl...
Effects of EGFR inhibition or activation on immortalized-human esophageal epithelial cells. EPC2-hTE...
Figure S3. CRISPR/Cas9 mediated HDACs inhibition and evaluation of tumor cell growth inhibition in e...
Figure S2. Relative mRNA levels of EGFR, ErbB2, and ErbB3 in pancreatic cancer cells. Parental HPAF-...
Assessment of receptor negative cells for E2-mediated PR upregulation. Relative steady state levels ...
Figure S1. AZD9291 pretreatment inhibited GBM cell migration. The cells were pretreated with AZD9291...
Figure S3. Characterization of the sorted EGFP+ and EGFP− cells freshly isolated from the MDA-MB-231...
Figure S1. Phosphohistone H3 (pHH3) expression and rhabdomyoblast count in VCR and ENT + VCR-treated...
CD3 levels in 4T1 tumors grown in wild-type BALB/c mice. Samples were from the experiment shown in F...
Figure S4. (A) WNT inhibitor drug Cardamonin (CAS 19309–14-9) decreased cell proliferation in 5-8F, ...
Figure S2. Combined rhein and EGFR inhibitors synergistically suppress pancreatic cancer cell prolif...